Charles Handy spent the first half of his career working for Shell and the London Business School, and the second half questioning corporate values. Here, he reveals why change is good.
While Irish start-ups seem to have no trouble raising seed capital, when it comes to bringing in the big bucks they struggle
High net worth individuals are piling into the capital, focusing on property as the best way to get a return for their huge sums of money
The Teeling family are in discussions with a number of investors about selling a 20 per cent stake in the Great Northern Distillery for around €5 million.
Industry giants Lafarge and Holcim agree new merger terms to create the largest cement company in the world. Philip Connolly reports
The New York-based fashion house Ralph Lauren, founded and owned by the eponymous designer, has established two Irish companies with a combined share capital of $5 billion to run significant parts of the global fashion empire.
The effects of the ECB’s quantitative easing programme may drive Europe’s currency even lower
TV presenter Glenda Gilson is fighting potential restrictions against her taking a role as a company director as she plans to set up her own media production company, The Sunday Business Post has learned.
Smurfit is a father of seven. His son, Dermot Junior, is chief executive of GameAccount Network, a software company specialising in the gambling trade that is growing rapidly.
Nama’s redundancy costs are set to be about €20 million as the agency accelerates its wind-down.
Powerflute, the paper company controlled by the Smurfit family, is in line to earn around €4 million as it sells out of a Finnish paper mill.
A mere 22 men and their associated companies ended up owing the Irish banks €25.6 billion by the time the country’s property bubble burst. As revealed in detail today in the PwC dossier, each of the men faced huge financial pressure when the report was produced.
IMAP’s Jurgis Oniunas gives his assessment of the current trends driving the global M&A market, writes Philip Connolly.
Irish pharmaceutical start-up Inflection Biosciences has raised €750,000 from private investors as it moves forward with the pre-clinical development of a cutting edge cancer treatment.